The first canine influenza vaccine has now been approved.

Intervet/Schering-Plough Animal Health is pleased to inform you that a new tool to help broaden protection against canine respiratory disease has now received a conditional license from the USDA. Canine Influenza Vaccine, H3N8 is the first vaccine to offer protection against this serious emerging disease.

More information can be found on the USDA website: www.aphis.usda.gov

Administered as a subcutaneous injection followed by a second dose 2-4 weeks later, the vaccine is packaged in two convenient presentations: 25 x 1 mL and 5 x 10 mL (practical for shelter environments). It will be available for purchase in the beginning of July and will be officially launched at AVMA on July 12.

For more information, please contact your Intervet/Schering-Plough Animal Health or Distributor representative, or call Intervet/Schering-Plough Animal Health technical
support at 800-224-5318.